IceCure Medical Ltd.
corporate_fare Company Profile
IceCure Medical Ltd. (NASDAQ:ICCM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 48 items for ICCM at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- IceCure Medical confirms reverse split as key to Nasdaq compliance, capital strategy
- IceCure's ProSense® Shows Strong Kidney Cancer Efficacy, Drives Breast Cryoablation Interest at ECIO 2026
- IceCure Medical Receives 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance
- Nasdaq Grants IceCure 180-Day Extension for Bid Price Compliance
- IceCure Medical Launches New $4.34M At-The-Market Offering
Financial Snapshot
Insider Transactions
ICCM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.